1. Home
  2. AAP vs LQDA Comparison

AAP vs LQDA Comparison

Compare AAP & LQDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Advance Auto Parts Inc.

AAP

Advance Auto Parts Inc.

HOLD

Current Price

$54.56

Market Cap

3.1B

ML Signal

HOLD

LQDA

Liquidia Corporation

HOLD

Current Price

$38.52

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AAP
LQDA
Founded
1929
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.1B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
AAP
LQDA
Price
$54.56
$38.52
Analyst Decision
Hold
Strong Buy
Analyst Count
17
11
Target Price
$53.50
$41.00
AVG Volume (30 Days)
1.4M
1.0M
Earning Date
05-21-2026
05-07-2026
Dividend Yield
1.77%
N/A
EPS Growth
113.01
51.81
EPS
0.73
N/A
Revenue
$8,601,000,000.00
$158,320,000.00
Revenue This Year
$0.33
$278.87
Revenue Next Year
$2.50
$57.13
P/E Ratio
$77.42
N/A
Revenue Growth
N/A
1031.18
52 Week Low
$30.48
$11.85
52 Week High
$70.00
$46.67

Technical Indicators

Market Signals
Indicator
AAP
LQDA
Relative Strength Index (RSI) 55.95 54.11
Support Level $51.90 $31.75
Resistance Level $62.28 $39.19
Average True Range (ATR) 2.18 1.93
MACD 0.43 0.29
Stochastic Oscillator 63.36 58.78

Price Performance

Historical Comparison
AAP
LQDA

About AAP Advance Auto Parts Inc.

Advance Auto Parts is a leading auto-parts retailer in North America with more than 4,000 store and branch locations. About half of the firm's sales are geared toward the professional channel, with the remaining sales in the do-it-yourself market. Through its vast store footprint and distribution network, Advance manages thousands of stock-keeping units for various vehicle makes and models. The retailer primarily competes on inventory availability and service speed, making the operating efficiency of its hub-and-spoke distribution model critical to meeting customer needs.

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.

Share on Social Networks: